Imv Inc (IMV)

0.75
0.00(0.00%)
  • Volume:
    26,631
  • Bid/Ask:
    0.73/0.75
  • Day's Range:
    0.71 - 0.78

IMV Overview

Prev. Close
0.75
Day's Range
0.71-0.78
Revenue
271.51K
Open
0.78
52 wk Range
0.6-2.4
EPS
-0.524
Volume
26,631
Market Cap
61.84M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
40,975
P/E Ratio
-1.26
Beta
1.85
1-Year Change
-65.75%
Shares Outstanding
82,452,187
Next Earnings Date
Nov 10, 2022
What is your sentiment on Imv Inc?
or
Market is currently closed. Voting is open during market hours.

Imv Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Imv Inc Analysis

Imv Inc Company Profile

Imv Inc Company Profile

Employees
97
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA44974L1031
  • CUSIP:44974L103

IMV Inc. is a clinical-stage immuno-oncology company. The Company is focused on developing a portfolio of therapies based on DPX, an immune-educating technology platform, that is designed to inform a specific anti-tumor immune response, offering benefit to patients with solid or hematological cancers. Its lead candidate, maveropepimut-S (MVP-S) is a DPX-based immunotherapy that targets survivin-expressing cells for elimination by educated, cytotoxic T cells. Its other candidates include DPX-RSV and DPX-COVID-19. DPX-RSV is a DPX-based vaccine candidate targeting the respiratory syncytial virus (RSV) strain A. It is focused on developing DPX-COVID-19, a vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using its DPX platform. The Company is also developing maveropepimut-S for the treatment of breast and ovarian cancer, as well as for Diffuse large B-cell lymphoma (DLBCL) and other malignancies.

Read More

Analyst Price Target

Average3.93 (+423.39% Upside)
High6
Low1.9014
Price0.75
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsBuySellStrong SellStrong SellStrong Sell
SummaryNeutralSellStrong SellStrong SellStrong Sell
  • 2.7 soon
    0
    • Positive news coming out soon on Preclinical trial for Covid19 vaccine. They have introduce some virus variant/mutation in the development. Market Cap. only $300 millions.
      0
      • projections for earnings..?
        0
        • Earnings on 6th, call on 10th.
          0
          • what's next for this?
            0
            • Any new news?
              0
              • below 5....
                1
                • why though
                  0
                • I don't get it either ...
                  0
              • Absolutely Huge News Today!  The growth is just getting started
                0
                • what news
                  0
                • oh you haven't heard? I thought everyone has heard.. the bird is the word. 🎶🎶🎶🎶
                  0
                • doesn't seem to be growing...
                  0
              • what do you guys think ??
                0
                • Going back up now.... hope it breaks $5 EOD
                  0